肺炎链球菌中青霉素结合蛋白PBP3在大肠杆菌中的可溶性表达及活性鉴定

【目的】克隆肺炎链球菌R6的pbp3基因,构建原核表达载体并转化大肠杆菌表达,为PBP3的结构及应用研究创造条件。【方法】利用PCR法克隆肺炎链球菌R6中N端截短的pbp3基因(15-413 aa),BamHⅠ和XhoⅠ酶切后插入pGEX-6p-1构建pGEX-6p-pbp3*表达质粒,在大肠杆菌BL21(DE3)中胞内表达GST-PBP3融合蛋白,Glutathione-Sepharose 4B column亲和纯化GST-PBP3融合蛋白,PreScission Protease切除GST标签,再次过谷胱甘肽亲和层析柱获得纯化的PBP3蛋白。利用PBP3对头孢喹诺的结合试验来鉴定表达蛋白是否有活性。【结果】经测序鉴定成功扩增出N端截短的pbp3基因,成功构建了pGEX-6p-pbp3*表达载体,并纯化出可溶性PBP3蛋白,而且有活性。【结论】肺炎链球菌pbp3基因原核表达系统的成功构建以及有活性重组蛋白的获得,为PBP3蛋白的结构及应用研究奠定了基础。     

非洲猪瘟病毒CP204L基因的原核表达与单抗制备

由非洲猪瘟病毒(ASFV)引起的非洲猪瘟(ASF)给我国养猪业带来了不可估量的经济损失,严重阻碍了我国养猪业的发展,研发ASFV快速诊断试剂是目前最重要的内容之一。CP204L基因编码ASFV结构蛋白p30。本研究以克隆ASFV的CP204L基因为基础,通过基因重组技术,加入His标签,将构建的重组质粒命名为pET-28a-CP204L。将重组质粒转化至大肠杆菌BL21(DE3)感受态细胞,37℃经1mmol/L异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达6h,表达蛋白进行SDS-PAGE鉴定和Western Blot检测。重组蛋白纯化后免疫小鼠制备筛选单克隆抗体,Western Blot和IFA验证单抗的结合特异性。结果表明,重组的pET-28a-CP204L诱导后表达蛋白为30kD,以不可溶性包涵体形式存在;表达蛋白利用His标签进行纯化,获得纯化蛋白2mg,单克隆抗体筛选获得5株IgG亚型的ASFV p30蛋白的单抗,且均具有良好的结合活性。本研究为发展ASFV检测方法提供了基础。     

肺炎链球菌血红素结合脂蛋白PiuA的表达、纯化和表征

【背景】肺炎链球菌是社区获得性肺炎最常见的致病菌之一,它也会引起脑膜炎、鼻窦炎、中耳炎、菌血症等一系列疾病,对人类(特别是儿童、老人、免疫缺陷患者)健康造成重大威胁。铁是肺炎链球菌生存和感染所必需的元素之一,其中血红素转运系统PiuABCD是肺炎链球菌最重要的铁转运系统。【目的】克隆、表达和纯化肺炎链球菌血红素转运系统脂蛋白PiuA,并在体外表征PiuA蛋白的血红素结合特性。【方法】将肺炎链球菌D39菌株中的piuA(spd_1652)基因连接到载体pBAD-HisA上,在大肠杆菌Top10菌株中进行异源表达,然后运用Ni-NTA亲和层析纯化PiuA-His蛋白,并用肠激酶切掉His标签获得不含标签的PiuA蛋白,最后运用圆二色谱、紫外光谱和荧光光谱表征PiuA蛋白的血红素结合特性。【结果】构建了pBAD/HisA-PiuA重组表达载体,获得了纯度大于95%的PiuA蛋白,圆二色谱显示PiuA蛋白与Hemin结合后,其二级结构不发生改变;紫外光谱结果显示PiuA蛋白具有血红素结合能力;荧光光谱结果显示apo-PiuA蛋白与Hemin结合常数K=3.4×10~5 L/mol。【结论】肺炎链球菌血红素转运系统脂蛋白PiuA能够特异地结合血红素,为肺炎链球菌的生存和感染提供必需的铁源,PiuA蛋白的体外表征结果为针对PiuABCD血红素转运系统设计抗菌药物奠定了基础。     

新型rhNDPK-A工程菌的构建及表达产物纯化研究

目的 :为简化纯化过程 ,获得有临床研究价值的rhNDPK -A蛋白 ,构建新型rhNDPK -A基因的表达质粒 ,利用 6×His标签以Ni+ -NTA亲和层析柱纯化蛋白。方法 :将抑癌基因nm2 3-H1从质粒PBVNMH1中亚克隆于带有纯化标签的表达载体pQE4 0中。IPTG诱导表达目的蛋白。通过镍离子螯合层析柱一步纯化法纯化目的蛋白。结果 :pQE - 4 0中亚克隆的nm2 3-H1序列完全正确 ;目的蛋白在大肠杆菌M15中的表达量可达 4 9.6 % ;Ni+ -NTA亲和层析柱一步纯化后蛋白纯度为 93%。结论 :构建了带有 6×His纯化标签的新型rhNDPK -A基因表达质粒pQE -nm2 3H1,所构建质粒能高效表达目的蛋白 ,利用Ni+ -NTA亲和层析柱简便高效地纯化了表达产物。     

LbCpf1基因的原核表达、纯化与体外切割检测

目的:为获得具有体外切割活性的LbCpf1蛋白。方法:将毛螺菌科细菌ND2006(Lachnospiraceae bacterium ND2006)的LbCpf1基因编码区连接至pHis*6(IV),构建原核表达质粒CRISPR-LbCpf1-6*His。将该重组质粒转化BL21(DE3)感受态细胞,IPTG诱导目的蛋白表达,经镍柱亲和层析纯化、透析除盐和凝胶电泳检测等步骤获得重组蛋白,进行体外切割试验鉴定重组蛋白切割活性。结果:双酶切鉴定和测序结果表明成功构建重组质粒CRISPR-LbCpf1-6*His,经转化后获得含有重组质粒CRISPR-LbCpf1-6*His的BL21(DE3)蛋白表达菌株。将菌株接种于37℃,160 r/min,IPTG终浓度为0.5 mmol/L的条件下诱导5 h,最终镍柱纯化除盐后的LbCpf1蛋白终浓度可达400 ng/μl,在体外适宜条件下,该重组蛋白可与成熟的crRNA结合切断标靶DNA。结论:获得的高纯度LbCpf1蛋白具有体外切割活性,可用于后续基因编辑研究。     

融合蛋白GST-Ulp1p在大肠杆菌中的高效可溶性表达及其活性鉴定

利用基因工程技术,体外重组小分子类泛素修饰蛋白酶1(Ulp1)的活性片段,获得高表达、高特异性重组蛋白酶。从酿酒酵母Saccharomyces cerevisia中提取Ulp1编码第403到621个氨基酸残基之间的DNA片段(Ulp1p),在其C端加入6×His并连接到大肠杆菌表达载体pGEX中,构建重组表达质粒pGEX-Ulp1p-his6。将重组质粒转化至大肠杆菌Rosetta(DE3)中,氨苄青霉素抗性筛选转化子。表达、纯化后,以SUMO融合蛋白检测其活性。经过优化,该蛋白可溶性表达,表达量占菌体总蛋白的40.12%。可通过谷胱甘肽琼脂糖凝胶柱或Ni-NTA凝胶亲和层析纯化得到纯度98%的蛋白。经酶切分析,比活力为1.375×104U/mg。融合蛋白GST-Ulp1p-His6无需切除谷胱甘肽S-转移酶(GST)标签,具有很高的活性,制备简易;6×His标签,有利于底物蛋白切割后纯化,减少蛋白损失。本研究为制备高活力的SUMO蛋白酶提供了一个新方法。     

单核细胞增生李斯特菌LadR蛋白对外排泵MdrL的调控机制研究

研究单核细胞增生李斯特菌(Listeria monocytogenes,Lm)调控子LadR对外排泵MdrL的调控作用及方式。采用同源重组技术构建ladR基因缺失菌株ΔladR;通过实时荧光定量PCR检测mdrL基因在野生株EGD-e和突变株ΔladR中的转录水平;构建重组蛋白表达菌株BL21(DE3)-ladR并纯化重组蛋白His6-LadR;通过凝胶阻滞试验检测LadR蛋白与mdrL基因启动子区域的结合活性。成功构建ladR基因缺失菌株ΔladR。与野生株EGD-e相比,突变株ΔladR中mdrL基因的转录水平提高约51倍;成功构建重组蛋白表达菌株BL21(DE3)-ladR,纯化得到浓度为1 mg/mL的重组蛋白His6-LadR;凝胶阻滞实验结果显示,重组蛋白His6-LadR可与mdrL基因的启动子区域特异性结合。Lm的调控子LadR通过与mdrL基因启动子区域特异性结合实现对外排泵MdrL的负调控。     

亲和标签在重组蛋白表达与纯化中的应用

亲和标签融合技术为重组蛋白的纯化提供了一种简单方便的纯化工具,具有结合特异性高、洗脱条件温和、通用性强、纯化倍数高等显著优点。概述了亲和标签对融合蛋白表达的影响,可以提高重组蛋白的产量,增强重组蛋白的可溶性,促进重组蛋白的正确折叠;回顾了在重组蛋白表达与纯化中广泛使用的几种亲和标签,以及近年来相继出现的几种比较新颖的纯化标签;介绍了亲和标签的组合使用策略,His6-MBP组合标签集合了两个标签的优点,串联亲和纯化可以纯化获得生理条件下的蛋白质复合体;展望了亲和标签未来的发展趋势,认为仍需继续开发性能更加优越、纯化效果更加显著的纯化标签系统。     

LbCpf1基因的原核表达、纯化与体外切割检测 *

目的:为获得具有体外切割活性的LbCpf1蛋白。方法: 将毛螺菌科细菌ND2006(Lachnospiraceae bacterium ND2006)的LbCpf1基因编码区连接至pHis*6(IV),构建原核表达质粒CRISPR-LbCpf1-6*His。将该重组质粒转化BL21(DE3)感受态细胞,IPTG诱导目的蛋白表达,经镍柱亲和层析纯化、透析除盐和凝胶电泳检测等步骤获得重组蛋白,进行体外切割试验鉴定重组蛋白切割活性。结果: 双酶切鉴定和测序结果表明成功构建重组质粒CRISPR-LbCpf1-6*His,经转化后获得含有重组质粒CRISPR-LbCpf1-6*His的BL21(DE3)蛋白表达菌株。将菌株接种于37 ℃,160 r/min,IPTG终浓度为0.5 mmol/L的条件下诱导5 h,最终镍柱纯化除盐后的LbCpf1蛋白终浓度可达400 ng/μl,在体外适宜条件下,该重组蛋白可与成熟的crRNA结合切断标靶DNA。结论: 获得的高纯度LbCpf1蛋白具有体外切割活性,可用于后续基因编辑研究。     

金属蛋白质组学研究锌离子匮乏对肺炎链球菌的影响

【目的】研究锌离子缺乏对肺炎链球菌的影响,找到其适应性生长机制。【方法】以肺炎链球菌为模型,利用加锌和不加锌的培养基对细菌进行培养,收集细胞蛋白,采用双向凝胶电泳,结合金属亲和层析和质谱技术鉴定差异表达蛋白,进而通过生物信息学分析蛋白质相互关系,从中找到细菌适应锌离子匮乏条件的关键代谢通路和蛋白。【结果】测定了在限制培养条件下肺炎链球菌的最适生长浓度,建立了锌离子调控蛋白双向凝胶电泳图谱,鉴定到了96个差异表达蛋白斑点,共67个差异蛋白,其中32个表达下调,35个表达上调,锌离子调控蛋白的作用可能主要体现在糖代谢、核酸代谢、氧化还原作用、辅助蛋白质翻译、合成及折叠等方面。建立了锌结合蛋白的差异表达图谱,鉴定到了10个差异表达蛋白斑点,共7个差异蛋白,其中1个表达下调,6个表达上调。锌离子结合蛋白的作用可能主要体现在应对压力、蛋白质折叠和转运、氨基酸代谢等方面。【结论】肺炎链球菌主要通过调控碳水化合物代谢和核酸代谢等多个代谢通路来应对宿主锌金属离子匮乏的环境,从而使自身能够存活并对宿主形成感染。本研究为揭示细菌在宿主环境,特别是金属离子匮乏条件下的适应性生长机制提供理论基础。     

Immune response and protective efficacy of S9 ribosomal protein of Streptococcus pneumoniae in a model of sepsis

Vaccination is the most promising strategy to reduce the incidence of pneumococcal infection. Although there are vaccines available, all of them are based on polysaccharide antigens (conjugated or not). In addition to their high cost, those vaccines do not cover all serotypes. To overcome these hindrances, we evaluated the immunogenicity and the protective efficacy of the S9 ribosomal protein of Streptococcus pneumoniae with the aim of developing a protein-based vaccine in the future. The gene encoding the S9 ribosomal protein was cloned in pET21-a expression vector, and the recombinant S9 protein was used to immunize mice. Significantly higher levels of anti-S9 immunoglobulin G were achieved (with predominance of immunoglobulin G1) in comparison with the control. Antibodies elicited against S.?pneumoniae protein extract in rabbit recognized the recombinant S9 protein by Western blot, thus demonstrating its immunogenicity. Moreover, mice immunized with recombinant S9 protein and challenged with a virulent strain of S.?pneumoniae presented a significant reduction of bacteremia after 24?h of infection as compared with the control. However, in the S9-immunized mice the onset of death was insignificantly delayed, but all of them died by the fourth day postinfection.     

Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus

Recombinant plectasin, the first fungus defensin, was expressed in Pichia pastoris and purified, and its physical, chemical and antimicrobial characteristics were studied. Following a 120 h induction of recombinant yeast, the amount of total secreted protein reached 748.63 μg/ml. The percentage of recombinant plectasin was estimated to be 71.79% of the total protein. After purification with a Sephadex G-25 column and RP-HPLC, the identity of plectasin was verified by MALDI-TOF MS. Plectasin exhibited strong antimicrobial activity against the Gram-positive bacteria Staphyloccocusaureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Streptococcus suis. At a concentration of 2560 μg/ml, this peptide showed approximately equal activity against S. aureus, S. epidermidis, S. suis, and S. pneumoniae, when compared to 320 μg/ml vancomycin, 640 μg/ml penicillin, 320 μg/ml vancomycin and 160 μg/ml vancomycin, respectively. In addition, plectasin showed anti-S. aureus activity over a wide pH range of 2.0 and 10.0, a high thermal stability at 100 °C for 1h and remarkable resistance to papain and pepsin. The expression and characterization of recombinant plectasin in P. pastoris has potential to treat Streptococcus and Staphyloccocus infections when most traditional antibiotics show no effect on them. Our results indicate that plectasin can be produced in large quantities, and that it has pharmaceutical importance for the prevention and clinical treatment of Staphyloccocus and Streptococcus infections.     

肺炎链球菌SpxA蛋白的原核表达、纯化及多克隆抗体的制备

目的 构建肺炎链球菌SpxA蛋白的原核表达系统,制备其多克隆抗体.方法 设计引物,利用PCR技术扩增肺炎链球菌D39菌株的spxA基因,并插入表达载体pET-28a（＋）内,测序鉴定.重组质粒转化至大肠埃希菌BL21（DE3）中,以IPTG诱导表达含6个组氨酸标签的SpxA重组蛋白,经Ni-NTA亲和层析柱纯化后,以其为抗原免疫BALB/c小鼠制备多克隆抗体.用ELISA及Western印迹方法分别检测多克隆抗体的效价及特异性.结果 从大肠埃希菌中诱导出高表达的SpxA重组蛋白,纯化后免疫小鼠获得抗血清,ELISA测定其效价可达1：2 560 000以上,Western印迹结果显示其能特异性地作用于肺炎链球菌SpxA.结论 成功构建了pET-28a（＋）-spxA原核表达质粒,获得了高纯度的目的 蛋白和高滴度、高特异性的多克隆抗体.     

Host-vector system for integration of recombinant DNA into chromosomes of transformable and nontransformable streptococci.

We describe a genetic system in which transformation of Streptococcus pneumoniae and Streptococcus sanguis was used to insert recombinant DNA into the conjugative chromosomal element omega (cat tetM) 6001 (omega 6001). The element containing the recombinant DNA was then transferred by conjugation to the chromosome of transformable and nontransformable streptococci. When Escherichia coli plasmid pDP36 was used as donor in transformation, it was capable of inserting 5.9 kilobases of heterologous DNA into the chromosome of competent streptococcal strains carrying omega 6001; the transformants were scored for erythromycin resistance. Genetic analysis showed that in a fraction of the erythromycin-resistant transformants the integration via flanking homology of the heterologous DNA caused inactivation of the tetM gene of omega 6001. By analyzing the stability of the resistance markers, we found that stable integration of heterologous DNA was achieved only in the erythromycin-resistant, tetracycline-sensitive transformants. It was possible to detect conjugal transfer of the heterologous sequences from stable transformants to strains of S. pneumoniae, S. sanguis, Streptococcus pyogenes, and Streptococcus faecalis. The omega 6001-pDP36 host-vector system opens new possibilities for gene transfer in streptococci. By this method cloned streptococcal DNA (possibly mutagenized in vitro) can be returned to the original host, greatly facilitating complementation tests and fine physiological studies.     

Heteroduplex DNA mismatch repair system of Streptococcus pneumoniae: cloning and expression of the hexA gene.

Mutations affecting heteroduplex DNA mismatch repair in Streptococcus pneumoniae were localized in two genes, hexA and hexB, by fractionation of restriction fragments carrying mutant alleles. A fragment containing the hexA4 allele was cloned in the S. pneumoniae cloning system, and the hexA+ allele was introduced into the recombinant plasmid by chromosomal facilitation of plasmid transfer. Subcloning localized the functional hexA gene to a 3.5-kilobase segment of the cloned pneumococcal DNA. The product of this gene was shown in Bacillus subtilis minicells to be a polypeptide with an Mr of 86,000. Two mutant alleles of hexA showed partial expression of the repair system when present in multicopy plasmids. A model for mismatch repair, which depends on the interaction of two protein components to recognize the mismatched base pair and excise a segment of DNA between strand breaks surrounding the mismatch, is proposed.     

Horizontal spread of an altered penicillin-binding protein 2B gene between Streptococcus pneumoniae and Streptococcus oralis

Abstract The region encoding the transpeptidase domain of the penicillin-binding protein 2B (PBP 2B) gene of two penicillin-resistant clinical isolates of Streptococcus oralis was > 99.6% identical in nucleotide sequence to that of a penicillin-resistant serotype 6 isolate of Streptococcus pneumoniae . The downstream 849 base pairs of these genes were identical. Analysis of the data indicates that the PBP gene has probably been transferred from S. pneumoniae into S. oralis , rather than vice versa, and shows that one region of this resistance gene has been distributed horizontally both within S. pneumoniae and into two different viridans group streptococci.     

C型凝集素LSECtin识别细菌的研究

目的:通过sLSECtin-Fc蛋白与细菌及细胞的黏附,寻找能与LSECtin结合的细菌。方法:通过ELISA检测sLSECtin-Fc与细菌的黏附,同时构建CHO-pDsRed1-N1-LSECtin稳定细胞株进行与细菌的黏附实验,荧光显微镜进行镜鉴拍照。结果:获得能够与sLSECtin-Fc蛋白黏附的细菌,并且通过过表达LSECtin的稳定株与细菌的黏附,发现LSECtin可以结合大肠杆菌和肺炎链球菌,而不能结合金黄色葡萄球菌和肺炎克雷伯杆菌。结论:发现LSECtin可以结合细菌,为进一步研究LSECtin在先天免疫中的作用奠定了基础。     

肺炎链球菌假想的溶菌酶样蛋白的活性分析和鉴定

目的 探索肺炎链球菌中一种假想的溶菌酶样蛋白的活性.方法 生物信息学分析该基因的功能结构域;利用长臂同源PCR对该基因进行敲除,观察D39野生菌和缺陷菌在生物学性状的改变;利用底物PNP-（GIcNAc）和溶壁微球菌,构建过表达载体,绘制生长曲线,对截断和全长蛋白的溶菌酶活性进行鉴定.结果 生物信息学分析结果显示该基因的编码产物为β-1,4-N-乙酰胞壁酸糖苷酶,属于糖基水解酶25家族;野生菌为长链生长,缺陷菌呈短链状;溶菌酶和假想的溶菌酶样蛋白均可使底物释放出游离的对硝基苯酚,A405nm吸光度值分别为1.166和0.792;同时也可使得溶壁微球菌发生溶解;含过表达质粒的肺炎链球菌较之野生菌,溶解较快.结论 假想的溶菌酶样蛋白具有溶菌酶活性,是一种新的溶菌酶.